Evidence map›Paper›PMID 42100423›Full record

ArticleFrontiers in oncology2026

Plasma expression of long non-coding RNA

Anica Pravdic Divac, Natasa Tosic, Zorica Cvetkovic, Marko Radulovic, Teodora Karan-Djurasevic, Aleksandra Tomic, Irena Marjanovic, Natasa Stanisavljevic, Branka Zukic, Olivera Markovic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anica Pravdic Divac *Department of Hematology, University Clinical-Hospital center "Bezanijska kosa", Belgrade, Serbia.
Natasa Tosic *Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Zorica CvetkovicDepartment of Hematology, University Clinical-Hospital center Zemun, Belgrade, Serbia.
Marko RadulovicClinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia.
Teodora Karan-DjurasevicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Aleksandra TomicDepartment of Hematology, University Clinical-Hospital center Zemun, Belgrade, Serbia.
Irena MarjanovicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Natasa StanisavljevicDepartment of Hematology, University Clinical-Hospital center "Bezanijska kosa", Belgrade, Serbia.
Branka ZukicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Olivera MarkovicDepartment of Hematology, University Clinical-Hospital center "Bezanijska kosa", Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Long non-coding RNAs (lncRNAs) participate in pathogenesis, progression and therapy resistance in multiple myeloma (MM). Growth Arrest-Specific 5 ( Methods and material: 73 newly diagnosed patients with MM and 16 healthy volunteers were recruited from Clinical Hospital Centre (CHC) "Bežanijska Kosa" and CHC "Zemun" in the period from July 2020 to December 2024. Blood samples were collected before starting therapy. Demographic, laboratory and clinical parameters, prognostic score, overall response rate, progression free survival (PFS) and overall survival (OS) were analyzed. Relative quantification analysis of the Results: No significant difference was found between plasma expression Conclusion: This is the first study showing prognostic potential of circulating lncRNA

Indexed as

GAS5 expressionlong-non coding RNAmultiple myelomaplasmaprognosis

Identifiers

PMID42100423
PMCPMC13143772

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.